NCT04773301

Comparative Study Between Levobupivacaine and Ropivacaine in the Hip Fractures of the Elderly

Randomized and Controlled Phase IV Clinical Trial on the Analgesic Effectiveness of the Combined Blockade in the Hip Fractures of the Elderly: Comparative Study Between Levobupivacaine and Ropivacaine

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 114 (actual)
• Sponsor: Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León · Academic / Other
• Sex: All
• Age: 65 Years
• Healthy volunteers: Not accepted

Summary

Prospective, low-level, non-commercial intervention, comparative clinical trial (phase IV) of balanced, randomized groups, to compare the analgesic efficacy of the local anesthetics Ropivacaine and Levobupivacaine in peripheral nerve block in hip fracture surgery in the elderly .

Detailed description

There are several studies that try to identify the ideal anesthetic for the management and control of pain in hip fracture surgery in the elderly. The optimum would be to use an anesthetic with the lowest possible latency, since this will favor the start of surgery. And, at the same time, with a more lasting analgesia with the least motor impairment. Therefore, it is essential to collect data on efficacy (effective block that allows us to mobilize the patient), latency, and analgesic scales appropriate to the cognitive state of the study sample.

Conditions

• Hip Fractures

Interventions

Type	Name	Description
DRUG	Levobupivacaine	Local anaesthetic drug belonging to the amino amide group. It is the S-enantiomer of bupivacaine
DRUG	Ropivacaine	Local anaesthetic drug belonging to the amino amide group. The name ropivacaine refers to both the racemate and the marketed S-enantiomer.

Timeline

• Start date: 2021-02-13
• Primary completion: 2021-11-26
• Completion: 2021-12-01
• First posted: 2021-02-26
• Last updated: 2024-07-19
• Results posted: 2024-07-19

Locations

1 site across 1 country: Spain